Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: animal experiment

August 5, 2024 Drug delivery / Pharma applications

Pulmonary Vasodilating Effects of a New Drug Formulation Containing a NO Donor Metabolite (SIN-1A) stabilized by CD

Sin1A is an unstable NO releasing metabolite of Molsidomine. Molsidomine is a prodrug that undergoes first-pass metabolism in the liver,

Continue reading

December 18, 2020 Drug delivery / Pharma applications

Novel drug for oral treatment against Covid-19

Nature Microbiology reported on an orally efficacious ribonucleoside analogue inhibitor of influenza viruses, MK-4482/EIDD-2801, that was repurposed for use against

Continue reading

Recent Posts

  • Cyclodextrins Target Inflammatory Foam Cells in Multiple Sclerosis Lesions
  • FDA Approves LEMBAZ for Infantile-Onset Niemann-Pick Disease
  • HPBCD beads for drug delivery
  • FDA Clears Cyclarity’s UDP-003 Trial for Heart Disease
  • Special issue: Cyclodextrin‑Based Advanced Formulations

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (28)
  • Analysis (75)
  • CD as API (364)
  • CD derivatives (447)
  • Cosmetics and toilettry (55)
  • Diagnosis (15)
  • Drug delivery (835)
  • E-ducation (64)
  • Environmental (144)
  • Events (243)
  • Food (239)
  • Gene delivery (22)
  • Household products (6)
  • In Hungarian (4)
  • Life sciences (46)
  • Non-pharma applications (429)
  • Other industrial use (115)
  • Pharma applications (1,247)
  • Supramolecular systems (45)
  • Uncategorized (178)

Top Posts

  • FDA Approves LEMBAZ for Infantile-Onset Niemann-Pick Disease
  • Cyclodextrins Target Inflammatory Foam Cells in Multiple Sclerosis Lesions
  • 16th Central European Symposium on Pharmaceutical Technology (CESPT 2027)
  • Toruzyme® for synthesizing cyclodextrins from starch
  • MIT scientists filed patent for HPBCD treatment in Alzheimer's disease
  • Cyclodextrin for treating lymphedema
  • FDA Clears Cyclarity’s UDP-003 Trial for Heart Disease
  • Special Issue of the journal Materials "Cyclodextrin-Based Nanomaterials: Synthesis, Properties, and Applications”
  • Lanosterol eye drops for cataract treatment
  • Positively Charged Fluorine-Free Cyclodextrin Nanosponges for PFAS Removal

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,472 other subscribers
Loading Comments...